首页 | 本学科首页   官方微博 | 高级检索  
     


Anti-androgens increase N-terminal pro-BNP levels in men with prostate cancer
Authors:Dockery Frances  Bulpitt Christopher J  Agarwal Sanjiv  Vernon Clare  Nihoyannopoulos Petros  Kemp Martin  Hooper James  Rajkumar Chakravarthi
Affiliation:Departments of Medicine for the Elderly,;Urology,;Oncology and;Cardiology, Imperial College, Hammersmith Hospital, London and;Department of Clinical Biochemistry, Royal Brompton Hospital, London, UK
Abstract:Objective The aim of this study was to determine the effects of anti‐androgens on left ventricular (LV) function and levels of N‐terminal proB‐type natriuretic peptide (NT‐proBNP), a sensitive cardiac risk marker, in men with prostate cancer as these are widely used drugs in this condition, and evidence suggests that endogenous androgens are cardioprotective in men. Design and patients Forty‐three men (mean age 70·7 ± 6·2 years) with prostate cancer were randomized to goserelin (an LH‐releasing hormone analogue) or bicalutamide (an androgen‐receptor blocker) for 6 months; 20 men with a history of prostate cancer on no treatment were studied in parallel. Results Mean changes in testosterone and oestradiol, respectively, from baseline to 6 months were –88% and –46% with goserelin, +50% and +44% with bicalutamide, and –1% and –9% for the ‘no‐treatment’ group. Bicalutamide significantly increased NT‐proBNP from baseline to 3 and 6 months (median value at baseline, 3 and 6 months: 55, 101 and 118 ng/l, respectively). Goserelin caused a significant increase from baseline to 3 months but not to 6 months (median value at baseline, 3 and 6 months: 66, 87 and 72 ng/l, respectively). No significant changes occurred in the ‘no‐treatment’ cohort (median value at baseline 3 and 6 months: 60, 53 and 60 ng/l, respectively). No significant changes in LV function, blood pressure (BP), body mass index or waist–hip ratio occurred to account for the changes in NT‐proBNP. Conclusion Androgen receptor blockade and, to a lesser extent, androgen suppression cause an increase in NT‐pro‐BNP in men with prostate cancer. The significance is not clear but could imply an adverse effect on cardiovascular risk following hormonal manipulation.
Keywords:
本文献已被 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号